Pharming Group N.V. (PHAR) Accounts Payables (2019 - 2024)

Pharming (PHAR) has disclosed Accounts Payables for 6 consecutive years, with $66.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accounts Payables fell 8.16% year-over-year to $66.6 million, compared with a TTM value of $66.6 million through Dec 2024, down 8.16%, and an annual FY2024 reading of $66.6 million, down 8.16% over the prior year.
  • Accounts Payables was $66.6 million for Q4 2024 at Pharming, down from $72.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $72.5 million in Q4 2023 and bottomed at $42.5 million in Q4 2021.
  • Average Accounts Payables over 5 years is $56.5 million, with a median of $54.5 million recorded in 2022.
  • The sharpest move saw Accounts Payables dropped 8.23% in 2021, then soared 33.16% in 2023.
  • Year by year, Accounts Payables stood at $46.3 million in 2020, then dropped by 8.23% to $42.5 million in 2021, then grew by 28.23% to $54.5 million in 2022, then soared by 33.16% to $72.5 million in 2023, then decreased by 8.16% to $66.6 million in 2024.
  • Business Quant data shows Accounts Payables for PHAR at $66.6 million in Q4 2024, $72.5 million in Q4 2023, and $54.5 million in Q4 2022.